Tuesday's podcasts stories
Pfizer agrees to licensing deal for COVID-19 pill
Pfizer announced on Tuesday it will allow low and middle-income countries to make and distribute the company’s COVID-19 pill inexpensively. The move is an attempt to increase the global supply in 95 poorer nations.
While the deal helps treat patients, the company has not made the same decision when it comes to its COVID-19 vaccine.
Axios Re:Cap host Felix Salmon is joined by Axios health care business reporter Bob Herman to discuss Pfizer’s decisions and the global ramifications.
Out-of-network costs spin out of control
People who have health insurance but get sick with diseases that require out-of-network care can face staggering costs.
- Plus, the future of at-home COVID testing.
- And, Florida’s special legislative session against mask and vaccine mandates.
Guests: Axios' Bob Herman, Kia Kokalitcheva and Selene San Felice.
Credits: Axios Today is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Sara Kehaulani Goo, Julia Redpath, Alexandra Botti, Nuria Marquez Martinez, Alex Sugiura, Sabeena Singhani, Lydia McMullen-Laird, and Jayk Cherry. Music is composed by Evan Viola. You can reach us at [email protected]. You can text questions, comments and story ideas to Niala as a text or voice memo to 202-918-4893.
Go deeper:
What SpaceX’s recent successes mean for its ambitions
Last week brought a spate of updates on SpaceX's programs. There was a major test of its Starship engines, the spacecraft that could someday be used to bring humans to the moon. SpaceX’s Crew2 mission to and from the International Space Station returned safely. And finally, Axios Space reporter Miriam Kramer caught up with SpaceX’s first all-civilian crew about life after space.
Axios Re:Cap host Felix Salmon is joined by Miriam Kramer to unpack what all of these events tell us about SpaceX’s near-term plans, future ambitions and lines of business.
Progressives worry about getting their spending agenda passed
House Democrats continue to push for a vote of that nearly $2 trillion Build Back Better spending bill. After months of wrangling, no date has been set and passage of President Biden’s massive agenda remains in question. So one question we’re asking this morning is: Is all the momentum lost?
- Plus, IBM’s quantum computing ambitions.
- And, Conclusions after the global climate summit.
Guests: Axios' Hans Nichols, Ina Fried and Ben Geman.
Credits: Axios Today is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Sara Kehaulani Goo, Julia Redpath, Alexandra Botti, Nuria Marquez Martinez, Alex Sugiura, Sabeena Singhani, Lydia McMullen-Laird, and Jayk Cherry. Music is composed by Evan Viola. You can reach us at [email protected]. You can text questions, comments and story ideas to Niala as a text or voice memo to 202-918-4893.